Full details on the methods followed are available to the reader from the online access link to the registered systematic review protocol in the International prospective register of systematic reviews PROSPERO:
Material S1. Supplementary methods and search strategy Table S1 . Participants, interventions, comparators, and outcomes in the included trials. Table S2 . Participants, interventions, comparators, and outcomes in trials eligible but not providing numerical data for the analysis. Table S3 . Assessing risk of bias in trials eligible. 
None
$ Target values were set on the basis of baseline bSO2 measurement. ¥ only serum S100B was dosed. 0.2659/0.3492/0.0864 § The following outcomes providing numerical data were considered: (A) peri-/post-operative death, and (B) post-operative acute kidney function deterioration and (C) cardiovascular events occurrence. † For both INVOS and non-INVOS system for monitoring, the NIRS target values presented were ranked according to probabilities for being the best, the second best, the third best, and so on !(# = %), % = 1, … , * following Markov chain Monte Carlo methods. ‡ SUCRA for each target value # out of the * competing target values requires calculation of the * vector of the cumulative probabilities +,-.,/ to be among the % best target value, % = 1, … , *. NAs, non-assessable; NIRS, near-infrared spectroscopy; SOC, standard or care; SUCRA, surface under the cumulative ranking area. 
